Is Indivior Pharmaceuticals Inc overvalued?

Indivior Pharmaceuticals Inc (INDV) looks undervalued — trading about 39% below its fair value.

Undervalued

Price

$36.28

Fair value

$50.59

Current P/E

12.1

Normal P/E

16.8

Market cap

$4.53B

Dividend yield

22.4%

Return on equity

-352.9%

Sector

Healthcare

Fair value compares INDV's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks